• Assessment of benefits and risks of probiotics in baby foods Bifidobacterium lactis Bb12. 

      Halvorsen, Ragnhild; Narvhus, Judith; Lassen, Jørgen Fr; Midtvedt, Tore; Rugtveit, Jarle; Yazdankhah, Siamak Pour; Andersen, Lene Frost; Frølich, Wenche; Frøyland, Livar; Haugen, Margaretha; Høiby, Anne; Kapperud, Georg; Lunestad, Bjørn Tore; Meltzer, Helle Margrete; Nesbakken, Truls; Nygård, Karin Maria; Robertson, Lucy; Olsvik, Ørjan; Paulsen, Jan Erik; Tranulis, Michael A.; Tryland, Morten; Rimstad, Espen (Research report; Forskningsrapport, 2010-05-14)
      The Norwegian Scientific Committee for Food Safety (VKM) has appointed an ad hoc-group of experts to answer a request from the Norwegian Food Safety Authority regarding benefit and risk assessment of B. lactis Bb12 in baby foods focusing on the age groups 4-6 months, 6-12 months and 1-3 years. This assessment is based on the literature provided by the notifier as well as that found by a MEDLINE search.
    • Risk assessment on use of Lactobacillus rhamnosus (LGG) as an ingredient in infant formula and baby foods (II) 

      Rimstad, Espen; Andersen, Lene Frost; Frølich, Wenche; Frøyland, Livar; Halvorsen, Ragnhild; Høiby, Ernst Arne; Kapperud, Georg; Lunestad, Bjørn Tore; Lassen, Jørgen Fredrik; Meltzer, Helle Margrete; Narvhus, Judith Ann; Nygård, Karin; Nesbakken, Truls; Olsvik, Ørjan; Paulsen, Jan Erik; Robertson, Lucy Jane; Tranulis, Michael A.; Tryland, Morten; Vainio, Kirsti; Haugen, Margaretha (Research report; Forskningsrapport, 2007-06-15)
      On 10. March 2006 , The Norwegian Food Safety Authority (Mattilsynet) decided that, on the basis of VKM’s previous risk assessment (2005), Nutramigen 1 with Lactobacillus rhamnosus GG (LGG) could not be marketed in Norway as medical foods for infants (0-4 months). In addition, The Norwegian Food Safety Authority (Mattilsynet) decided (08. November ...